Frontiers in Immunology (Jan 2024)

B cell receptor repertoire abnormalities in autoimmune disease

  • Hayato Yuuki,
  • Takahiro Itamiya,
  • Takahiro Itamiya,
  • Yasuo Nagafuchi,
  • Yasuo Nagafuchi,
  • Mineto Ota,
  • Mineto Ota,
  • Keishi Fujio

DOI
https://doi.org/10.3389/fimmu.2024.1326823
Journal volume & issue
Vol. 15

Abstract

Read online

B cells play a crucial role in the immune response and contribute to various autoimmune diseases. Recent studies have revealed abnormalities in the B cell receptor (BCR) repertoire of patients with autoimmune diseases, with distinct features observed among different diseases and B cell subsets. Classically, BCR repertoire was used as an identifier of distinct antigen-specific clonotypes, but the recent advancement of analyzing large-scale repertoire has enabled us to use it as a tool for characterizing cellular biology. In this review, we provide an overview of the BCR repertoire in autoimmune diseases incorporating insights from our latest research findings. In systemic lupus erythematosus (SLE), we observed a significant skew in the usage of VDJ genes, particularly in CD27+IgD+ unswitched memory B cells and plasmablasts. Notably, autoreactive clones within unswitched memory B cells were found to be increased and strongly associated with disease activity, underscoring the clinical significance of this subset. Similarly, various abnormalities in the BCR repertoire have been reported in other autoimmune diseases such as rheumatoid arthritis. Thus, BCR repertoire analysis holds potential for enhancing our understanding of the underlying mechanisms involved in autoimmune diseases. Moreover, it has the potential to predict treatment effects and identify therapeutic targets in autoimmune diseases.

Keywords